Poland· PL-100237472
Lipa fix
A medicinal product containing tiliae flos, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Tiliae flos
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990028467
- gtin05909990028474
- gtin05909990028481
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiliae flos in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3a03526-ab52-4666-96af-c51c0935706a GET /v1/drugs/c3a03526-ab52-4666-96af-c51c0935706a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zioła do zaparzania w saszetkach",
"source": "urpl",
"strength": "-",
"packaging": "05909990028467 ¦ OTC ¦ 62651\n20 sasz. 1,5 g\n05909990028474 ¦ OTC ¦ 62652\n26 sasz. 1,5 g\n05909990028481 ¦ OTC ¦ 62653\n30 sasz. 1,5 g",
"substance": "Tiliae inflorescentia ad 1000,000 mg",
"common_name": "Tiliae flos",
"pl_product_id": "100237472",
"pozwolenie_nr": "IL-2746/LN",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about tiliae flos.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.